SecBot SecBot

LAB

STANDARD BIOTOOLS INC.
Nasdaq· Laboratory Analytical Instruments· Inc. DE· CIK 0001162194 Industrials & Manufacturing
$0.6200 −0.09 (−12.68%)
Nov 16 4:00 PM ET · prev $0.7100
Market cap
$257.2M
Micro cap
Median target
$1.35
+118% · range $1.35–1.35
1 year
−48.8%
from $1.21 · Nov 17
30 days
−3.1%
from $0.6400
52-week range
$0.6000–1.68
−63% from high · low Oct 26
Avg volume 20D
838.9K
shares / day
Short interest
2.17M
≈0.6% of shares · −11.3%
Days to cover
3.1
at average volume
Insider net
+$46.9K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
19
analyzed by SecBot
SecBot read MIXED 13 reports · 90 days
Balance 1 bearish · 2 bullish · 10 neutral oldest → newest, height = score
Avg score ·High conf. 6/13

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $46.9K at an average $0.6253. No open-market sales.

  • InstitutionsMIXED

    Q3 2026: 17 added (0 new), 12 trimmed or exited.

  • Short sellersSTEADY

    Short interest −11.3% to 2.17M shares. 3.1 days to cover, ≈0.6% of shares.

  • TrendDOWNTREND

    8% below its 50-day average.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPADD3,369,536$2.5M
RENAISSANCE TECHNOLOGIES LLCDOUBLED2,043,858$1.5M
JANE STREET GROUP, LLCTRIM714,877$529.4K
Rockefeller Capital Management L.P.ADD579,267$429.0K
HighTower Advisors, LLCADD461,030$341.4K
Invesco Ltd.ADD377,612$279.7K
Russell Investments Group, Ltd.DOUBLED171,809$127.2K
OSAIC HOLDINGS, INC.DOUBLED150,943$107.2K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Nov 2025
12-month targets · 1 analysts

Price is below the lowest target. Median implies +118%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 5, 2025TD Cowen
MAINTAIN
MAINTAINHold
Feb 27, 2025Keybanc
DOWNGRADE
DOWNGRADESector Weight
Oct 31, 2024TD Cowen
MAINTAIN
MAINTAINBuy
Aug 1, 2024TD Cowen
MAINTAIN
MAINTAINBuy
Apr 16, 2024TD Cowen
INITIATE
INITIATEBuy
Apr 4, 2024Jefferies
INITIATE
INITIATEBuy

Insider ledger

Form 4
$46.9K
bought · 1 insider
$0
sold · 0 insiders
−0.8%
vs their $0.6253 cost
DateInsiderTypeValue
Nov 5, 2026
Carey Thomas D.
Director
Nov 5, 2026
BUY$46.9K
Aug 20, 2026
Egholm Michael
President & CEO
Aug 20, 2026
TAX W/H$65.6K
Aug 20, 2026
Mackay Sean
SVP & Chief Business Officer
Aug 20, 2026
TAX W/H$17.3K
Aug 20, 2026
Kim Hanjoon Alex
Chief Financial Officer
Aug 20, 2026
TAX W/H$18.9K
Aug 3, 2026
Egholm Michael
President & CEO
Aug 3, 2026
TAX W/H$314.8K
Jul 23, 2026
Kim Hanjoon Alex
Chief Financial Officer
Jul 23, 2026
TAX W/H$181.2K
Jun 20, 2026
Mackay Sean
SVP & Chief Business Officer
Jun 20, 2026
AWARD500,000 sh
Jun 18, 2026
Cox Troy
Director
Jun 18, 2026
AWARD175,923 sh

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current QNoneNoneNo data$0.00
Next QNoneNoneNo data$0.00
Current FYNoneNoneNo data$0.00
Next FYNoneNoneNo data$0.00

Short side

FINRA· Oct 30, 2026
2,169,887
shares short
-11.3%
vs prior settlement
3.1
days to cover
≈0.6%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 10, 2026 Earnings calendar
LAB Q3 2026 Earnings Scheduled · 2026-11-10
Nov 5, 2026 Insider
Carey Thomas D. bought 75,000 shares
Director @ $0.6253 ($46.9K)
Nov 3, 2026 SEC
Standard BioTools announced the closing of the sale of its Microfluidics business to ARCHIMED, which will operate as…
425 · Impact 3/10
Nov 3, 2026 Press
ARCHIMED has completed its acquisition of Standard BioTools' Microfluidics Business, which will operate as a…
Impact 3/10
Oct 5, 2026 Press
Standard BioTools announced the sale of its Microfluidics business to ARCHIMED, a healthcare-focused investment firm…
Impact 4/10
Sep 30, 2026 Inst.
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP · ADD
3,369,536 shares ($2.5M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

19 filings · 4 press releases · 5 bullish · 3 bearish · 1 mixed · 10 neutral
All LAB filing & press-release reports (23)